<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04789213</url>
  </required_header>
  <id_info>
    <org_study_id>MemorialBahcelievler1</org_study_id>
    <nct_id>NCT04789213</nct_id>
  </id_info>
  <brief_title>Mortality, Morbidity and Risk Factors of Liver Retransplantation</brief_title>
  <official_title>Comparison of Mortality, Morbidity and Risk Factors in Living- Donor and Deceased-Donor Liver Retransplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Bahçelievler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Bahçelievler Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the short and long term outcomes of living donor and deceased&#xD;
      donor liver retransplantation. Bearing that in mind, the investigators will retrospectively&#xD;
      analyze the files of patients whom underwent a liver retransplantation in Memorial&#xD;
      Bahcelievler Hospital Organ Transplantation Center.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival ratio</measure>
    <time_frame>1 minutes</time_frame>
    <description>Overall graft and patient survival ratio</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>10 minutes</time_frame>
    <description>Postoperative complications such as septicemia, hepatic artery thrombosis etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peri-operative informations</measure>
    <time_frame>15 minutes</time_frame>
    <description>Peri-operative informations such as blood loss during surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Test Results</measure>
    <time_frame>20 minutes</time_frame>
    <description>Patients' blood test results specific to liver such as International Normalization Ratio</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <condition>Liver Transplant Rejection</condition>
  <condition>Liver Transplant Failure</condition>
  <condition>Liver Diseases</condition>
  <condition>Liver Cirrhosis</condition>
  <condition>Liver Failure</condition>
  <condition>Organ Transplant Failure or Rejection</condition>
  <arm_group>
    <arm_group_label>Patients with Living Donor Liver Transplantation</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Deceased Donor Liver Transplantation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liver Transplantation</intervention_name>
    <description>Liver Transplantation</description>
    <arm_group_label>Patients with Deceased Donor Liver Transplantation</arm_group_label>
    <arm_group_label>Patients with Living Donor Liver Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with liver failure who underwent a second liver transplantation (i.e.&#xD;
        re-transplantation)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having a liver retransplantation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  N/A&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kamil Yalçın Polat, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Bahçelievler Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kamil Yalçın Polat, Prof.</last_name>
    <phone>+90 444 7 888</phone>
    <email>kamilypolat@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Memorial Bahçelievler Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34700</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamil Yalçın Polat, Prof</last_name>
      <phone>(0212) 408 45 45</phone>
      <phone_ext>4212</phone_ext>
      <email>kamilypolat@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>April 10, 2021</last_update_submitted>
  <last_update_submitted_qc>April 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Memorial Bahçelievler Hospital</investigator_affiliation>
    <investigator_full_name>Kamil Yalçın Polat</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

